Oxidative Stress [comd]
asymmetric dimethylarginine [aapp, phsu]
Associated [qlco]
cardiovascular complications [patf]
Haemodialysis [topp]
Patients [podg]
Improvement [cnce]
L-Arginine [aapp, bacs, phsu]
Intake [ftcn]
Background [cnce]
Aim [idcn]
High [qlco]
Incidence [qnco]
Cardiovascular disease [dsyn]
Chronic kidney disease [dsyn]
Patients [podg]
Result [ftcn]
Relation [famg]
Oxidative Stress [comd]
endothelial dysfunction [dsyn]
Inflammation [patf]
This [euka]
Study [mnob]
investigate [ftcn]
development [phsf]
Process [bpoc]
CKD [dsyn]
Patients [podg]
Receive [qlco]
treatment [ftcn]
Haemodialysis [topp]
Examined [fndg]
Modulating [spco]
Effect [qlco]
Oral [spco]
Arginine [aapp, bacs, phsu]
Patients [podg]
CVD, NOS [dsyn]
Methods [inpr]
Study [mnob]
included [ftcn]
Healthy Volunteers [popg]
Renal [bpoc]
Patients [podg]
divided [ftcn]
Renal Impairment [dsyn]
free [ftcn]
CVD, NOS [dsyn]
Suffering [mobd]
CVD, NOS [dsyn]
CVD, NOS [dsyn]
Patients [podg]
GIVEN [cnce]
Oral [spco]
Arginine [aapp, bacs, phsu]
g/day [qnco]
g% [qnco]
i d [topp]
Blood [tisu]
Level [qlco]
asymmetric dimethylarginine [aapp, phsu]
Malondialdehyde [orch]
homocysteine [aapp, bacs]
myeloperoxidase activity [moft]
Estimated [qnco]
Result [ftcn]
MDA [orch, phsu]
homocysteine [aapp, bacs]
Elevated [qlco]
Renal Impairment [dsyn]
Group [idcn]
CVD, NOS [dsyn]
Patients [podg]
experience [menp]
High [qlco]
Levels [qlco]
High [qlco]
activity [dora]
reduction [npop]
Parameters [fndg]
Observed [ftcn]
CVD, NOS [dsyn]
Patients [podg]
Following [tmco]
L-Arginine [aapp, bacs, phsu]
Intake [ftcn]
Conclusion [idcn]
recommend [idcn]
MDA [orch, phsu]
homocysteine [aapp, bacs]
cardiovascular risk factor [dsyn]
CKD [dsyn]
Patients [podg]
Focus [spco]
Attention [menp]
CARDIOVASCULAR [bdsy]
L-Arginine [aapp, bacs, phsu]
Patients [podg]
Copyright [inpr]
basel [hcro]
